• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

唐氏综合征和神经管缺陷的产前生化筛查。

Prenatal biochemical screening for Down's syndrome and neural tube defects.

作者信息

Wald N J, Kennard A

机构信息

Wolfson Institute of Preventive Medicine, Medical College of St. Bartholomew's Hospital, London, UK.

出版信息

Curr Opin Obstet Gynecol. 1992 Apr;4(2):302-7.

PMID:1373963
Abstract

Antenatal serum screening for Down's syndrome is now becoming established in many centers throughout the world. The screening method is based on the measurement of alpha-fetoprotein, unconjugated estriol, and human chorionic gonadotropin between 15 and 22 weeks of pregnancy. These measurements, used in conjunction with a woman's age, provide risk estimates of having a pregnancy with Down's syndrome for every woman screened. By identifying the 5% of women with highest risk and offering them an amniocentesis, about 60% of Down's syndrome pregnancies can be identified. If an ultrasound scan examination is used routinely to estimate gestational age, the detection rate can be increased by 5% to 10%. Recent information on the distribution of the three serum markers in twin pregnancies and pregnancies with insulin-dependent diabetes mellitus now means that screening can be carried out in such pregnancies. Various other serum markers of Down's syndrome have been reported, but at present they do not have a place in routine antenatal screening for Down's syndrome. The role of amniotic fluid acetylcholinesterase measurement, alone and in combination with amniotic fluid alpha-fetoprotein measurement, in the antenatal diagnosis of open neural tube defects has recently been clarified. The best policy is to perform an amniotic fluid alpha-fetoprotein measurement as the primary test and an acetylcholinesterase determination for those women who have an amniotic fluid alpha-fetoprotein measurement of two times the normal median or greater. The acetylcholinesterase can be measured either by the standard method (gel electrophoresis) or by a new quantitative monoclonal antibody method.

摘要

目前,唐氏综合征的产前血清筛查在全球许多医疗中心已逐渐确立。筛查方法是基于在妊娠15至22周期间测量甲胎蛋白、游离雌三醇和人绒毛膜促性腺激素。这些测量结果与孕妇年龄相结合,可为每位接受筛查的孕妇提供怀有唐氏综合征胎儿的风险评估。通过识别出风险最高的5%的孕妇并为她们提供羊膜穿刺术,大约60%的唐氏综合征妊娠能够被识别出来。如果常规使用超声扫描检查来估算孕周,检出率可提高5%至10%。最近有关双胎妊娠和胰岛素依赖型糖尿病妊娠中这三种血清标志物分布的信息,意味着现在可以对这类妊娠进行筛查。已经报道了唐氏综合征的各种其他血清标志物,但目前它们在唐氏综合征的常规产前筛查中并无用武之地。羊水乙酰胆碱酯酶测量单独及与羊水甲胎蛋白测量联合在开放性神经管缺陷产前诊断中的作用,最近已得到明确。最佳策略是将羊水甲胎蛋白测量作为主要检测方法,对于羊水甲胎蛋白测量值为正常中位数两倍或更高的孕妇进行乙酰胆碱酯酶测定。乙酰胆碱酯酶可以通过标准方法(凝胶电泳)或新的定量单克隆抗体方法进行测量。

相似文献

1
Prenatal biochemical screening for Down's syndrome and neural tube defects.唐氏综合征和神经管缺陷的产前生化筛查。
Curr Opin Obstet Gynecol. 1992 Apr;4(2):302-7.
2
Prenatal screening using maternal serum alpha-fetoprotein, human chorionic gonadotropin, and unconjugated estriol: two-year experience in a health maintenance organization.使用母体血清甲胎蛋白、人绒毛膜促性腺激素和未结合雌三醇进行产前筛查:在一家健康维护组织中的两年经验。
J Matern Fetal Med. 1996 Mar-Apr;5(2):70-3. doi: 10.1002/(SICI)1520-6661(199603/04)5:2<70::AID-MFM4>3.0.CO;2-N.
3
Reducing the need for amniocentesis in women 35 years of age or older with serum markers for screening.减少35岁及以上有血清标志物用于筛查的女性进行羊膜穿刺术的需求。
N Engl J Med. 1994 Apr 21;330(16):1114-8. doi: 10.1056/NEJM199404213301603.
4
Prenatal screening for Down's syndrome using inhibin-A as a serum marker.使用抑制素A作为血清标志物进行唐氏综合征的产前筛查。
Prenat Diagn. 1996 Feb;16(2):143-53. doi: 10.1002/(SICI)1097-0223(199602)16:2<143::AID-PD825>3.0.CO;2-F.
5
The role of maternal serum alpha-fetoprotein, human chorionic gonadotrophin and oestriol in the antenatal screening of Down's syndrome.母体血清甲胎蛋白、人绒毛膜促性腺激素和雌三醇在唐氏综合征产前筛查中的作用。
Med J Malaysia. 1994 Dec;49(4):351-4.
6
Down's syndrome: current screening techniques.唐氏综合征:当前的筛查技术。
South Med J. 1989 Dec;82(12):1483-6.
7
[Maternal serum screening for Down syndrome and neural tube defects].[孕母血清唐氏综合征和神经管缺陷筛查]
Ned Tijdschr Geneeskd. 1998 Feb 21;142(8):409-15.
8
Serum markers for Down's syndrome in relation to number of previous births and maternal age.唐氏综合征血清标志物与既往分娩次数及母亲年龄的关系。
Prenat Diagn. 1996 Aug;16(8):699-703. doi: 10.1002/(SICI)1097-0223(199608)16:8<699::AID-PD919>3.0.CO;2-P.
9
Experience on triple markers serum screening for Down's syndrome fetus in Hat Yai, Regional Hospital.合艾地区医院对唐氏综合征胎儿进行三联标志物血清筛查的经验。
J Med Assoc Thai. 2007 Oct;90(10):1970-6.
10
[Noninvasive serum test for prenatal detection of Down syndrome, other chromosome abnormalities and open neural tube defects--a prospective study].[用于产前检测唐氏综合征、其他染色体异常及开放性神经管缺陷的非侵入性血清检测——一项前瞻性研究]
Geburtshilfe Frauenheilkd. 1994 Jun;54(6):355-61. doi: 10.1055/s-2007-1022854.

引用本文的文献

1
Prenatal Screening of Trisomy 21: Could Oxidative Stress Markers Play a Role?21三体综合征的产前筛查:氧化应激标志物能发挥作用吗?
J Clin Med. 2021 May 28;10(11):2382. doi: 10.3390/jcm10112382.
2
Antenatal diagnosis of congenital heart disease and Down's syndrome: the potential effect on the practice of paediatric cardiology.先天性心脏病和唐氏综合征的产前诊断:对儿科心脏病学实践的潜在影响。
Br Heart J. 1995 Aug;74(2):192-8. doi: 10.1136/hrt.74.2.192.